parsaclisib

Incyte pulls FDA filing for cancer drug approval over confirmatory study, following Gilead out of the exit
Fierce Biotech
Wed, 01/26/22 - 10:57 am
Incyte
FDA
parsaclisib
Innovent, Incyte sign collaboration deal for three clinical-stage product candidates
Pharmaceutical Business Review
Mon, 12/17/18 - 09:02 am
Incyte
Innovent Biologics
pemigatinib
itacitinib
parsaclisib